Institution of Mother and Child, Warsaw, Poland Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2015
NCT03676569
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Anna Raciborska | Institute of Mother and Child | Institute of Mother and Child, Warsaw, Poland | Institution of Mother and Child, Warsaw, Poland | Mother and Child Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Drug Resistant Epilepsy (Phase 1)

Epilepsy (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 6